| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/26/2022 | 5.26% | Stifel | $5 → $3 | Downgrades | Buy → Hold |
| 05/12/2021 | 285.96% | Roth Capital | $9 → $11 | Maintains | Buy |
| 03/03/2021 | 215.79% | Roth Capital | $6 → $9 | Maintains | Buy |
| 01/13/2021 | 110.53% | Roth Capital | $5.5 → $6 | Maintains | Buy |
| 05/12/2020 | 40.35% | Stifel | $5 → $4 | Maintains | Buy |
| 01/04/2019 | 145.61% | Stifel | $9 → $7 | Maintains | Buy |
| 10/26/2018 | 215.79% | Stifel | → $9 | Initiates Coverage On | → Buy |
Iridex Questions & Answers
The latest price target for Iridex (NASDAQ: IRIX) was reported by Stifel on August 26, 2022. The analyst firm set a price target for $3.00 expecting IRIX to rise to within 12 months (a possible 5.26% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Iridex (NASDAQ: IRIX) was provided by Stifel, and Iridex downgraded their hold rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Iridex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Iridex was filed on August 26, 2022 so you should expect the next rating to be made available sometime around August 26, 2023.
While ratings are subjective and will change, the latest Iridex (IRIX) rating was a downgraded with a price target of $5.00 to $3.00. The current price Iridex (IRIX) is trading at is $2.85, which is out of the analyst's predicted range.
